Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Strategies for multivessel revascularization in patients with diabetes.

Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V; FREEDOM Trial Investigators.

N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4.

2.

Vorapaxar in the secondary prevention of atherothrombotic events.

Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA; TRA 2P–TIMI 50 Steering Committee and Investigators.

N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24.

3.

Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model.

Christensen CW, Rieder MA, Silverstein EL, Gencheff NE.

Circulation. 1995 Nov 1;92(9):2617-21.

4.

Utilization of the Wallstent for the treatment of innominate vein obstruction: a case report.

Gencheff NE, Schmidt DH, Jean WJ, Bajwa TK.

Cathet Cardiovasc Diagn. 1994 Jun;32(2):182-6.

PMID:
8062374
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk